Search

everythinglearnresearchcommunity

for

Search:↓

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

A male with aromatase deficiency improved bone health with estradiol treatment.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Finasteride inhibits enzyme activity in rhesus macaques, suggesting they're useful for evaluating similar drugs.

Men with baldness have higher levels of specific proteins, suggesting local hormone production may play a role in hair loss.

An 81-year-old woman's severe male hormone symptoms were caused by an ovarian tumor, which was treated with surgery.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Acne is an important sign of androgen excess disorders in women.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Dutasteride does not impair mental function in elderly men with enlarged prostate.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Finasteride and dutasteride reduce neurosteroid production, possibly helping treat glioblastoma.

Aromatase inhibitors cause male pattern hair loss in women.

Curcumin and its derivatives can block an enzyme important for making testosterone, with one derivative being particularly strong.